tradingkey.logo
tradingkey.logo
검색

Aytu Biopharma Inc

AYTU
관심 목록에 추가
2.160USD
+0.010+0.47%
종가 07/01, 16:00ET시세는 15분 지연됩니다
23.18M시가총액
손실P/E TTM

자세한 내용은 Aytu Biopharma Inc 회사

Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.

Aytu Biopharma Inc 정보

종목 코드 AYTU
회사 이름Aytu Biopharma Inc
상장일Oct 20, 2017
CEODisbrow (Joshua R)
직원 수82
유형Ordinary Share
회계 연도 종료Oct 20
주소7900 E. Union Avenue
도시DENVER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호80237
전화17204376580
웹사이트https://aytubio.com/
종목 코드 AYTU
상장일Oct 20, 2017
CEODisbrow (Joshua R)

Aytu Biopharma Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--

자주 묻는 질문

Aytu Biopharma Inc의 상위 5대 주주는 누구인가요?

Aytu Biopharma Inc의 상위 5대 주주는 다음과 같습니다: Mr. Jarrett T. (Josh) Disbrow

Aytu Biopharma Inc(AYTU)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Aytu Biopharma Inc의 주식을 보유한 기관은 총 69곳이며, 이들이 보유한 주식의 총 가치는 약 3.87M로 전체 발행 주식의 36.10%를 차지합니다. 이는 2025Q4 대비 -493525.00 증가한 수치입니다.

Aytu Biopharma Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Aytu Biopharma Inc의 ADHD portfolio 부문이 가장 높은 매출을 기록했으며, 금액은 13.22M로 전체 매출의 87.15%를 차지했습니다.